Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/06/2008WO2008060693A3 Tetracyclic imidazole analogs
11/06/2008WO2008057802A3 Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
11/06/2008WO2008054786A3 Methods and compositions for inhibiting gsk-3 in glial cell related disorders
11/06/2008WO2008054675A3 Antidiabetic bicyclic compounds
11/06/2008WO2008054508A3 Stable nanosized amorphous drug
11/06/2008WO2008048340A3 Cationic steroid antimicrobial compositions for treating poxvirus infections
11/06/2008WO2008042571A3 Substituted indole compounds
11/06/2008WO2008042216A3 Methods, kits, and compositions for generating new hair follicles and growing hair
11/06/2008WO2008039994A3 Targeted photodynamic therapy agent
11/06/2008WO2008039829A3 Diphenylheterocycle cholesterol absorption inhibitors
11/06/2008WO2008038119A3 A composition comprising a coenzyme q10 - cyclodextrin - complex and a carotene and use thereof for the treatment of pathologic states of e.g. the central nervous system
11/06/2008WO2008036966A3 Methods and compositions for the treatment of inflammation, obesity and related metabolic disorders
11/06/2008WO2008036316A3 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/06/2008WO2008034123A3 Polymeric conjugates containing positively-charged moieties
11/06/2008WO2008033432A3 Immune modulation by chemically modified ribonucleosides and oligoribonucleotides
11/06/2008WO2008033365A3 Amino ion releasing hydrogen bonded molecule
11/06/2008WO2008033352A3 Monocarboxylates for modifying macrophage function
11/06/2008WO2008027949A3 Thieno pyrimidine compounds
11/06/2008WO2008027837A3 Small molecule potentiator of hormonal therapy for breast cancer
11/06/2008WO2008024977A3 Isoquinoline, quinazoline and phthalazine derivatives
11/06/2008WO2008021432A3 Compositions and methods for treatment of conditions affecting the nervous system
11/06/2008WO2008020962A3 Cholesterol lowering drug combination
11/06/2008WO2008020306A3 Isoindole derivatives
11/06/2008WO2008017925A3 Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids
11/06/2008WO2008013633A3 Treating sex steroid responsive disorders
11/06/2008WO2008011462A3 Process for preparing solifenacin and its salts
11/06/2008WO2008011216A3 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
11/06/2008WO2008011169A3 Controlled release formulations and associated methods
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
11/06/2008WO2008006093A3 Estrogen receptor modulators and uses thereof
11/06/2008WO2007150018A3 Steroid-containing sustained release intraocular implants and related methods
11/06/2008WO2007146553A3 N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2h)-pyrazineacetamide
11/06/2008WO2007143155A3 Sustained release pharmaceutical dosage form containing phenylephrine
11/06/2008WO2007136605A3 Aryl-fused spirocyclic compounds
11/06/2008WO2007134187A3 Processes for nitration of n-substituted imidazoles
11/06/2008WO2007127930A3 Compounds affecting gap junction activity
11/06/2008WO2007127475A3 Pyridazines for demyelinating diseases and neuropathic pain
11/06/2008WO2007126865A3 Leukotriene antagonists via nasal drug delivery
11/06/2008WO2007126841A3 Inhibition of alpha-synuclein toxicity
11/06/2008WO2007126765A3 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
11/06/2008WO2007121156A3 Rnai-mediated inhibition of histamine receptor h1-related conditions
11/06/2008WO2007120818A3 Compositions and methods for inhibiting adhesions
11/06/2008WO2007111992A3 Methods and compositions for treating hypercholesterolemia and atherosclerosis
11/06/2008WO2007110068A3 Novel isooxazole derivatives and their uses
11/06/2008WO2007109585A3 Bisphosphonate compounds and methods
11/06/2008WO2007109107A3 Atf4 as a therapeutic target in alzheimers disease and other neurological disorders
11/06/2008WO2007106721A3 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/06/2008WO2007103934A3 Compositions and methods of use of ritonavir for treating hcv
11/06/2008WO2007098047A3 Methods and compositions for the treatment of parkinson's disease
11/06/2008WO2007097992A3 Novel heterocyclic diphenyl ethers
11/06/2008WO2007064618A8 Methods for the treatment of muscle loss
11/06/2008WO2007053724A3 Crystalline forms of cefdinir potassium salt
11/06/2008US20080275432 Photodynamic foam composition and sclerosis treatment
11/06/2008US20080275272 Amine compounds and inhibiting neurotransmitter reuptake
11/06/2008US20080275258 antilipemic agents for regulation or prevention of obesity; food and tea drink; reacting a flavan-3-ol with formaldehyde; used in smaller amounts, plant extracts; enzyme inhibitor as hypotensive agents, antidiabetic agent, aging resistance, anticarcinogenic agent
11/06/2008US20080275238 4-(Hydroxyalkyl-)-piperazinyl(thio)acetamide derivatives for treatment of cardiovascular disorders; antiarrhythmia agents; intermittent claudication, angina, congestive heart failure and myocardial infarction; diabetes
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection
11/06/2008US20080275136 Use of Glycerol for Improving Cardiac Function
11/06/2008US20080275135 Resorcinol Derivatives and Their Use for Lowering Blood Pressure
11/06/2008US20080275134 Retinylamine derivatives; preventing photoreceptor degeneration
11/06/2008US20080275133 Local Administration of Retinoids to Treat Deficiencies in Dark Adaptation
11/06/2008US20080275131 Compositions of (-)-e-10-oh-nt and methods for their synthesis and use
11/06/2008US20080275130 Novel Derivatives of 3.5-Seco-4-Norcholestane and Use Thereof
11/06/2008US20080275129 Such as spinal chord injury by administration of guanabenz; glycosaminoglycans; ointments
11/06/2008US20080275128 Contacting skin with X-ray contrast media such as iopamidol; sunscreen, cosmetics; colon disorders
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275126 Aliphatic acid-containing n-halogenated amino acid formulations
11/06/2008US20080275125 Combination Composition
11/06/2008US20080275124 Powder of amino acids and method for producing the same
11/06/2008US20080275123 N-halogenated amino acid formulations
11/06/2008US20080275122 For contact lenses; surface treatment; respiratory disorders
11/06/2008US20080275121 For contact lenses; surface treatment
11/06/2008US20080275120 Leucine rich composition
11/06/2008US20080275119 Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN)
11/06/2008US20080275118 For treating dyed/colored hair without loss of color
11/06/2008US20080275117 Compositions and Methods Comprising Boswellia Species
11/06/2008US20080275116 Carboxilic acid derivatives
11/06/2008US20080275114 Benzenesulfonamide derivatives; irritable bowel syndrome; may be co-administered with drug for inflammatory bowel disease; chemokine receptor inhibitors;
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
11/06/2008US20080275111 Administering macelignan [(3,4-methylenedioxyphenyl)-7'-(4-hydroxy-3-methoxyphenyl)-8,8'-dimethylbutane)] or derivatives or a Myristica fragrans solvent extract to treat brain disorders; Huntington's, Parkinson's, Creutzfeldt-Jacob, Pick's, Wilson's, and Alzheimer's disease; antiepileptic agents
11/06/2008US20080275110 Increased oral absorption and/or transfer into blood circulation; foods, beverages; for lowering blood cholesterol levels
11/06/2008US20080275109 Drug, food or drink product containing proanthocyanidine derived from hop, hop bract or apple; prevents digestive diseases caused by Helicobacter pylori; freeze drying
11/06/2008US20080275108 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
11/06/2008US20080275107 Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
11/06/2008US20080275106 Anticancer and Antiprotozoal Dihydroartemisinene and Dihydroartemisitene Dimers with Desirable Chemical Functionalities
11/06/2008US20080275105 Thienyl-acylhydrazone derivatives; muscular disorders; antiischemic, hypotensive, and antispasmodic agents; cardiovascular and respiratory system disorders
11/06/2008US20080275104 Methods of treating juvenile type 1 diabetes mellitus
11/06/2008US20080275103 Reacting pyrrolylalkylcarbinole, furanylalkylcarbinole or thiophenylalkylcarbinole units; cyclodehydration, hydroboration, oxidation, palladium-catalyzed Suzuki-Miyaura cross-coupling; anticarcinogenic agents, antitumor, and antiproliferative agents; autoimmune and neurodegenerative diseases
11/06/2008US20080275102 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination
11/06/2008US20080275101 Citrate and phosphate salts of 5-[5-fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide for treatment of protein kinase related disorders; crystallization; pharmacokinetics
11/06/2008US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient
11/06/2008US20080275099 Solid Forms of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275097 Non-nucleoside reverse transcriptase inhibitors
11/06/2008US20080275096 Process for the preparation of valsartan
11/06/2008US20080275095 Packages
11/06/2008US20080275094 5-(1,3-Diaryl-1H-Pyrazol-4-1 Methylene)-Thiazolidine-2,4-Dione Derivatives Useful as Anticancer Agent
11/06/2008US20080275093 Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]-, (4-methyl-5-oxido-1,2,5-oxadiazol-3-yl)methyl ester; oxatriazole-5-ones and/or oxatriazole-5-imines etc. are linked to the diuretic compounds through one or more sites such as O, N, S; cardiovascular, diabetes, oxidatives stress
11/06/2008US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
1 ... 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 ... 7860